RESUMO
This article continues a series of reports on research developments of particular interest to those involved in the management of patients with heart failure. Summaries of the following trials, reported at the 75th Scientific Sessions of the American Heart Association held in Chicago, Illinois between 17th and 20th November 2002 are included: PROSPER; DIAL; home care monitoring trials; immune modulation therapy; COMPANION; and anaemia in heart failure.
Assuntos
American Heart Association , Processos Grupais , Anemia/diagnóstico , Anemia/terapia , Insuficiência Cardíaca/diagnóstico , Insuficiência Cardíaca/terapia , Serviços de Assistência Domiciliar , Humanos , Imunoterapia , Monitorização Fisiológica , Estados UnidosRESUMO
This article continues a series of reports on research developments related to the field of heart failure. Reports of presentations made at the Hot Line sessions of the European Society of Cardiology XXIV Congress held in Berlin, Germany, between 31 August and 4 September 2002 are included. Summaries of the results of the following trials are presented: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II.
Assuntos
Cardiologia , Ensaios Clínicos como Assunto/tendências , Sociedades Médicas , Europa (Continente) , Insuficiência Cardíaca/terapia , Humanos , Disfunção Ventricular Esquerda/terapiaRESUMO
This article continues a series of reports on recent research developments in the field of heart failure. Reports of two key presentations made at the European Society of Cardiology Heart Failure Update meeting held in Oslo, Norway from 8 to 11 June 2002, are included in this article. Summaries of the results of the RENEWAL (RENAISSANCE and RECOVER) and ATTACH studies, presented at the Hot Line sessions held during the meeting are reported.
Assuntos
Anticorpos Monoclonais/uso terapêutico , Insuficiência Cardíaca/tratamento farmacológico , Imunoglobulina G/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto , Receptores do Fator de Necrose Tumoral/uso terapêutico , Sociedades Médicas , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Etanercepte , Humanos , Infliximab , NoruegaRESUMO
This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the Scientific Sessions of the XXIII Annual Congress of the European Society of Cardiology. Summaries of the following clinical studies are included: WARIS-II, ESCAMI, PAFAC, RITZ-I and TIME.
